- Alnylam Pharmaceuticals (NASDAQ:ALNY): Q4 EPS of -$0.28 beats by $0.32.
- Revenue of $24M (+121.2% Y/Y) beats by $10.91M.
- Press Release
Alnylam Pharmaceuticals beats by $0.32, beats on revenue
Recommended For You
More Trending News
About ALNY Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| ALNY | - | - |
| Alnylam Pharmaceuticals, Inc. | ||